Device Trial Radar · NCT00926549
Ocular Imaging With Spectral Domain Optical Coherence Tomography
Last checked: Nov 19, 2026Latest source record: Jun 23, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
300
Planned (sponsor's estimate)
Start
May 2009
Primary completion
Sep 2009
Study completion Sep 2009
Sponsor
- Lead sponsor
- Yonsei UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 23, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 16 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with various ocular diseases.
Conditions
- Healthy
- Myopia
- Hypermetropia
Interventions
Spectral domain-OCT (Cirrus™ HD-OCT, Carl Zeiss Meditec AG)Device
macular cube scanning
Primary outcomes
What the sponsor says the trial is designed to measure.
- macular retinal thickness and volumeTime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Yonsei University College of Medicine, Gangnam Severance Hospital
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.